Bridgeway Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
1,338,291
+190,930
+17% +$1.27M 0.2% 148
2026
Q1
$6.25M Sell
1,147,361
-103,444
-8% -$580K 0.13% 232
2025
Q4
$8.76M Sell
1,250,805
-971
-0.1% -$7.6K 0.18% 164
2025
Q3
$9.68M Buy
1,251,776
+249,587
+25% +$1.95M 0.21% 148
2025
Q2
$8.73M Buy
+1,002,189
New +$7.26M 0.21% 148
2022
Q1
Sell
-74,875
Closed -$6.88M 1354
2021
Q4
$6.88M Buy
74,875
+7,625
+11% +$911K 0.13% 258
2021
Q3
$8.53M Sell
67,250
-11,000
-14% -$1.6M 0.16% 186
2021
Q2
$13M Hold
78,250
0.23% 119
2021
Q1
$14.2M Sell
78,250
-8,700
-10% -$2.02M 0.27% 104
2020
Q4
$17.4M Sell
86,950
-20,400
-19% -$4.15M 0.37% 75
2020
Q3
$23.5M Buy
107,350
+98,050
+1,054% +$20.8M 0.54% 35
2020
Q2
$1.77M Buy
+9,300
New +$1.63M 0.04% 473

Other funds holding TDOC

Bridgeway Capital Management's TDOC Position: Q2 2026 in Review

Bridgeway Capital Management increased its Teladoc Health (TDOC) stake by 17% in Q2 2026, buying an estimated $1.27M and bringing the position to 1,338,291 shares worth $11.3M. The position accounts for 0.2% of the portfolio, ranked #148.

Bridgeway Capital Management first reported a position in TDOC in Q2 2020 and has held it in 12 quarters since. The position peaked at $23.5M in Q3 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Bridgeway Capital Management held 1,338,291 shares of Teladoc Health worth $11.3M as of Q2 2026.
  • Bridgeway Capital Management bought 190,930 Teladoc Health shares in Q2 2026, an estimated $1.27M.
  • Teladoc Health made up 0.2% of Bridgeway Capital Management's portfolio in Q2 2026, its #148 holding.
  • Bridgeway Capital Management first reported a position in Teladoc Health in Q2 2020 and has held it in 12 quarters since.
  • Bridgeway Capital Management's Teladoc Health position peaked at $23.5M in Q3 2020.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.